Effects of Tildrakizumab on Epigenetic Age
Condition(s):Psoriasis; Aging; Epigenetic Disorder; Inflammation; SkinLast Updated:December 19, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Psoriasis; Aging; Epigenetic Disorder; Inflammation; SkinLast Updated:December 19, 2023Active, not recruiting
Condition(s):Plaque PsoriasisLast Updated:January 31, 2024Recruiting
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:July 13, 2023Active, not recruiting
Condition(s):Genital PsoriasisLast Updated:January 31, 2024Recruiting
Condition(s):Plaque PsoriasisLast Updated:March 3, 2023Completed
Condition(s):PsoriasisLast Updated:February 9, 2024Recruiting
Condition(s):Psoriasis VulgarisLast Updated:January 18, 2024Recruiting
Condition(s):Plaque PsoriasisLast Updated:December 8, 2021Terminated
Condition(s):Psoriasis VulgarisLast Updated:August 29, 2023Recruiting
Condition(s):Plaque PsoriasisLast Updated:February 15, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.